申请人:ICI PHARMA
公开号:EP0055562A2
公开(公告)日:1982-07-07
A cephalosporin derivative of the formula :-
in which R0 is a hydrogen atom or a methyl radical; R' is any one of the C-3 substituents from antibacterially-active cephalosporins known in the art; R2 is any one of the C-4 substituents from antibacterially-active cephalosporins known in the art; R3 is a hydrogen atom or a 1-6C alkoxy or 1-6C alkylthio radical; X1 is a sulphur or oxygen atom, a CH2 radical or a radical of the formula NR7 in which R7 is a hydrogen atom, a 1-6C alkyl, formyl or benzyl radical; X2 is a nitrogen atom or a radical of the formula
R4 and R7, and R5 and R6 are a variety of substituents which are described in the specification; and the pharmaceutically-acceptable acid- or base- addition salts thereof. Pharmaceutical compositions, manufacturing processes and intermediates are also described.
一种头孢菌素衍生物,其式为
其中 R0 是氢原子或甲基基;R'是本领域已知抗菌活性头孢菌素的 C-3 取代基中的任一种;R2 是本领域已知抗菌活性头孢菌素的 C-4 取代基中的任一种;R3 是氢原子或 1-6C 烷氧基或 1-6C 烷硫基; X1 是硫或氧原子、CH2 自由基或式 NR7 的自由基,其中 R7 是氢原子、1-6C 烷基、甲酰基或苄基; X2 是氮原子或式 NR7 的自由基。
R4 和 R7 以及 R5 和 R6 是说明书中描述的各种取代基;以及它们的药学上可接受的酸或碱加成盐。此外,还介绍了药物组合物、生产工艺和中间体。